Avatar photo

Lily Chang

2980 Posts
Introducing Neffy: a revolutionary nasal spray alternative to needle-based allergy treatments

Introducing Neffy: a revolutionary nasal spray alternative to needle-based allergy treatments

In the realm of medical advances, a significant breakthrough has emerged with the introduction of Neffy, a nasal spray that has received approval from the Food and Drug Administration. This innovative device stands out as the pioneering needle-free option for managing severe allergic reactions, offering significant relief to those with a deep fear of the injections typically associated with emergency treatments like the EpiPen. Dr. Michael Blaiss, a respected allergist at the Medical College of Georgia, highlights a common scenario in his practice: Patients are often reluctant to use traditional autoinjectors during allergy emergencies. Their apprehension is so great that…
Read More
Electric cars vs. gasoline cars: true cost of ownership depends on your zip code

Electric cars vs. gasoline cars: true cost of ownership depends on your zip code

The debate over whether electric vehicles (EVs) or traditional gasoline-powered cars offer better long-term value has intensified as EV prices have fallen and charging infrastructure has expanded. While EVs often come with a higher upfront cost, the potential savings on fuel and maintenance can make them an attractive option. However, the financial equation is far from simple, with factors such as location, driving habits and vehicle model playing crucial roles. A growing body of research indicates that the total cost of ownership (TCO) for electric vehicles can vary significantly depending on where you live. Studies have found that drivers in…
Read More
Eli Lilly’s weight-loss drug reduces risk of developing diabetes in long-term trial

Eli Lilly’s weight-loss drug reduces risk of developing diabetes in long-term trial

In a recent long-term research study published Tuesday, Eli Lilly reported that its popular weight-management drug significantly reduced the incidence of type 2 diabetes by 94 percent among overweight or obese adults who had prediabetic symptoms, compared to a control group that received a placebo. The late-stage study explored the effects of tirzepatide, the active compound in both Eli Lilly’s Zepbound weight-loss shot and the diabetes treatment Mounjaro. Over about three years, participants who received the highest weekly dose of tirzepatide experienced an average reduction in body weight of 22.9 percent, while those who took a placebo saw only a…
Read More
Alex Karp: billionaire vsionario discusses AI, war and the U.S. outlook

Alex Karp: billionaire vsionario discusses AI, war and the U.S. outlook

Nestled in his New Hampshire abode, Alex Karp, the enigmatic CEO of Palantir Technologies, shares his unconventional journey and insights in an in-depth interview. Sporting a signature look with salt-and-pepper curls and hot pink socks, Karp opens up about his unique perspective on life, technology, and national security. In his candid revelations, Karp admits that he never learned to drive, a fact he attributes first to poverty and then to abundance. His distrust extends beyond cars; he avoids bicycles and skis, wary of their propensity to get lost in thought. However, he credits tai chi with improving his attention span,…
Read More